Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGFILGRASTIM-CBQV: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

60.3%
Female
39.7%
Male

Age Information

The average age of patients reporting adverse events with PEGFILGRASTIM-CBQV is 55.2 years.

Geographic Distribution

The majority of adverse event reports for PEGFILGRASTIM-CBQV originate from US.

Report Summary & Outcomes

732
Total Reports
732
As Primary/Secondary Suspect
104
Deaths Reported
94
Hospitalizations
3
Life-Threatening
2
Disabilities

Reporting Timeline

First adverse event report: 20160101. Most recent report: 20250826. View full timeline →

More About PEGFILGRASTIM-CBQV

PEGFILGRASTIM-CBQV Full Profile Reports by Year Drug Interactions